Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04791202
Status:
UNKNOWN
Last Update Posted:
2021-03-16
First Post:
2021-03-08
Brief Title:
Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis
Sponsor:
Christine M Kleinert Institute for Hand and Microsurgery
Organization:
Christine M Kleinert Institute for Hand and Microsurgery
Study Overview
Official Title:
Hypertonic Dextrose Versus Corticosteroid Intra-Articular Injections for the Treatment of Trapeziometacarpal Arthritis A Prospective Double-blind Randomized Controlled Clinical Trial
Status:
UNKNOWN
Status Verified Date:
2021-03
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early osteoarthritis by corticosteroids by giving long standing effect and improving patients symptoms and function Over the past 5 years an increasing number of level I and level II studies have emerged examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis On the contrary there is limited data in small joints such as the temporomandibular joint
Detailed Description:
Carpometacarpal osteoarthritis OA is a degenerative condition of the hand that causes pain stiffness and weakness It is the second most common site of degenerative disease in the hand after arthritis of the distal interphalangeal joints The prevalence of symptomatic hand OA in people over 70 years of age has been estimated as 134 for men and 262 for women OA is more frequent in older age groups leading to considerable disability with a burden on health services and on the economy Risk factor for carpometacarpal osteoarthritis of the thumb includes being female middle age previous trauma repetitive use and inflammatory joint disease Lifetime prevalence of this condition approaches 10
Injections are a useful conservative treatment modality prior to considering surgical treatment Corticosteroid injection is helpful in the treatment of the disease but some patients gain only short-term benefits Evolving reports are showing promising results for the application of dextrose as an alternative method for the treatment of Carpometacarpal osteoarthritis based on their induction for growth factors and inflammatory mediators For instance prolotherapy has been used as a treatment of musculoskeletal pain with various etiologies It has been suggested that prolotherapy induces little inflammation and stimulates endogenous repair especially by prompting release of growth factors Dextrose is an agent commonly used for prolotherapy
The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early OA by corticosteroids by giving long standing effect and improving patients symptoms and function Over the past 5 years an increasing number of level I and level II studies have emerged examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis On the contrary there is limited data in small joints such as the temporomandibular joint
Injections are a useful conservative treatment modality prior to considering surgical treatment Corticosteroid injection is helpful in the treatment of the disease but some patients gain only short-term benefits Evolving reports are showing promising results for the application of dextrose as an alternative method for the treatment of Carpometacarpal osteoarthritis based on their induction for growth factors and inflammatory mediators For instance prolotherapy has been used as a treatment of musculoskeletal pain with various etiologies It has been suggested that prolotherapy induces little inflammation and stimulates endogenous repair especially by prompting release of growth factors Dextrose is an agent commonly used for prolotherapy
The evolving reports form recent studies are creating a promise on the potential use of dextrose injections for treating arthritis and replacing current method of treating early OA by corticosteroids by giving long standing effect and improving patients symptoms and function Over the past 5 years an increasing number of level I and level II studies have emerged examining the effect of intra-articular prolotherapy for the treatment of both hip and knee osteoarthritis On the contrary there is limited data in small joints such as the temporomandibular joint
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
True
Is an FDA AA801 Violation?:
None